Mupirocin Calcium Hydrate

莫匹罗星钙二水合物

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMupirocin Calcium Hydrate
Drug Alias NameMupirocinum Calcium HydrateMupirocine Calcium HydrateMupirocina Calcium HydrateBRL-4910F
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIsoleucyl-tRNA synthetase inhibitors
TargetsIsoleucyl-tRNA synthetase
Therapy Area/IndicationsStaphylococcal InfectionsGram-Positive Bacterial InfectionsBacterial Infections
Global Approved IndicationsStaphylococcal InfectionsGram-Positive Bacterial Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1985/03/26
Country/TerritoryCanadaUnited StatesAustralia +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsStaphylococcal Infections
Inactive IndicationsGram-Positive Bacterial InfectionsBacterial Infections

Other Information

ATC CodeD06AX09R01AX06
Related LinksDrugBankKEGG